3 Results for "

Hypouricemic effect

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Hypouricemic effect" in MCE Product Catalog:

Cat. No.: HY-162961
Target:  

Xanthine Oxidase

Research Areas:  

Metabolic Disease

Xanthine oxidase-IN-16 is potent and orally active xanthine oxidase (XO) inhibitor with an IC50 of 102 nM. Xanthine oxidase-IN-16 shows significant efficacy in hyperuricemia rats .
loading...
    loading...
Cat. No.: HY-153968
CAS No.: 2669726-78-5
Purity:  99.96%
Target:  

Xanthine Oxidase URAT1

Research Areas:  

Metabolic Disease

URAT1&XO inhibitor 1 (compound 29) is a dual inhibitor of both URAT1 (IC50=~10 μM) and Xanthine Oxidase (IC50=1.01 μM). URAT1&XO inhibitor 1 results hypouricemic effect in potassium oxonate-induced hyperuricemia rat model. URAT1&XO inhibitor 1 is used for hyperuricemia research .
loading...
    loading...
Cat. No.: HY-144456
CAS No.: 2276711-87-4
Target:  

Xanthine Oxidase

Research Areas:  

Metabolic Disease

Xanthine oxidase-IN-5 is an effective and orally active xanthine oxidase (XO) inhibitor with IC50 value of 0.70 μM. Xanthine oxidase-IN-5 displays favorable agent-like properties with ligand efficiency (LE) and lipophilic ligand efficiency (LLE) values of 0.33 and 3.41, respectively. Xanthine oxidase-IN-5 shows potent hypouricemic effects in hyperuricemic rat model .
loading...
    loading...